NVNO

NVNO

USD

enVVeno Medical Corporation Common Stock

$2.735-0.031 (-1.121%)

リアルタイム価格

Healthcare
医療機器
米国

価格チャート

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$2.766

高値

$2.766

安値

$2.660

出来高

0.00M

企業ファンダメンタルズ

時価総額

48.0M

業種

医療機器

United States

取引統計

平均出来高

0.09M

取引所

NCM

通貨

USD

52週レンジ

安値 $2.028現在値 $2.735高値 $6.48

関連ニュース

AccessWire

Virtual Investor "Top 5 for '25" Conference Hosted by JTC Now Available On-Demand

- Access video webcasts from the first wave of participating companies hereFRENCHTOWN, NJ / ACCESS Newswire / February 19, 2025 / JTC Team , a fully integrated corporate communications and investor

もっと見る
Virtual Investor "Top 5 for '25" Conference Hosted by JTC Now Available On-Demand
AccessWire

One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum

One-year follow-up data demonstrates sustained improvements across venous specific quality-of-life indicators.PMA application for the VenoValve submitted in November 2024, with an FDA decision expected in the

もっと見る
One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum
AccessWire

Interim Two-Year Follow-Up Data from the VenoValve(R) U.S. Pivotal Trial to be Presented Today at the VESS 2025 Annual Winter Meeting

Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.78% of subjects maintained a clinically meaningful

もっと見る
Interim Two-Year Follow-Up Data from the VenoValve(R) U.S. Pivotal Trial to be Presented Today at the VESS 2025 Annual Winter Meeting